25
1
4
1
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T25560 | JP-8g | JP 8g,JP8g | |
JP-8g has an anti-cancer and anti-inflammatory that acts through nitric oxide synthase signaling pathways. | |||
T24064 | Fipamezole | JP-1730,BVF-025,JP 1730,JP1730 | Adrenergic Receptor |
Fipamezole is a potent alpha2 adrenergic receptor antagonist that may be useful for studying autonomic dysfunction in Parkinson's disease. | |||
T22882 | JP1302 | Adrenergic Receptor | |
JP1302 is a selective α2C adrenoceptor antagonist with a Kb value of 16 nM and a Ki of 28 nM for human α2C receptors.JP1302 has antidepressant activity, disrupts the FACT complex and degrades histone H1.JP1302 has been u... | |||
T11726 | JP1302 dihydrochloride | Adrenergic Receptor | |
JP1302 dihydrochloride is a selective, high affinity antagonist of the alpha2C-adrenoceptor (α2C-adrenoceptor), with a Ki (binding affinity) value of 28 nM and a Kb value (antagonist activity) of 16 nM. | |||
T32313 | JP7 | JP-7,JP 7 | |
JP7 is a hemoglobin allosteric modifier. | |||
T27321 | Fipamezole HCl | MPV1730,JP1730,MPV-1730,MPV 1730,JP 1730,JP-1730 | |
Fipamezole HCl, a α2-adrenoceptor antagonist, is used potentially for the treatment of dyskinesia associated with Parkinson's disease. | |||
TQ0081 | JPH203 | KYT-0353 | Others |
JPH203 (KYT-0353) is a potent and specific inhibitor of L-type amino acid transporter protein 1 (LAT-1). JPH203 inhibits cellular uptake of leucine, inhibits cell proliferation, induces apoptosis, and possesses anti-infl... | |||
T8857 | LJP-1586 HCl | LJP 1586,LJP-1586 hydrochloride,LJP-1586,LJP1586 | Others |
LJP-1586 HCl, a highly selective inhibitor of vascular adhesion protein-1 (VAP-1), exhibits antiinflammation effect by reducing adhesion molecule expression and immune cell infiltration after intracerebral hemorrhage (IC... | |||
T11727 | JPH203 dihydrochloride | KYT-0353 dihydrochloride | Others |
JPH203 dihydrochloride (KYT-0353 dihydrochloride) is a tyrosine analog, acts as a selective inhibitor of L-type amino acid transporter 1 (LAT1), and is used in cancer research. | |||
T15626 | JPM-OEt | Others | |
JPM-OEt is a broad spectrum cysteine cathepsin inhibitor with antitumor activity. JPM-OEt binds covalently in the active site and irreversibly inhibits the cysteine cathepsin family. | |||
T32315 | JPB 25 | BRN0977600,JPB25,BRN-0977600,JPB-25,BRN 0977600 | |
JPB 25 is a bioactive chemical. | |||
T74454 | JPS016 | ||
JPS016, a benzamide-based Von Hippel-Lindau (VHL) E3-ligase proteolysis targeting chimera (PROTAC), effectively degrades class I histone deacetylase (HDAC). It serves as a potent HDAC1/2 degrader, resulting in a signific... | |||
T74456 | JPS036 | ||
JPS036, a benzamide-based Von Hippel-Lindau (VHL) E3-ligase proteolysis targeting chimera (PROTAC), efficiently degrades class I histone deacetylase (HDAC), particularly HDAC1/2. Its activity results in a substantial inc... | |||
T77938 | JPS016 TFA | HDAC | |
JPS016, a benzamide-based Von Hippel-Lindau (VHL) E3-ligase proteolysis targeting chimera (PROTAC), effectively degrades class I histone deacetylase (HDAC), particularly HDAC1/2. This activity is associated with a substa... | |||
T79524 | JPC0323 | 5-HT Receptor | |
JPC0323 is a dual positive allosteric modulator of the 5-HT2C and 5-HT2A receptors, featuring on-target properties, acceptable plasma exposure, and adequate brain penetration. It is utilized in research pertaining to neu... | |||
T77966 | SJPYT-195 | ||
SJPYT-195 is a cytotoxic agent targeting GSPT1 for degradation, suitable for PROTAC (PROteolysis TArgeting Chimera) synthesis [1]. | |||
T71056 | SJP-L-5 | ||
SJP-L-5 is a inhibitor of HIV-1 infection by blocking viral DNA nuclear entry. | |||
T74149 | JPD447 | ||
JPD447, a derivative of MAC-0547630, represents a new class of UppS inhibitors designed to enhance the efficacy of β-lactam antibiotics. | |||
T74650 | JPE-1375 | ||
JPE-1375, a complement C5a receptor 1 (C5aR1) antagonist, effectively inhibits polymorphonuclear leukocyte mobilization (EC50=6.9 µM) and reduces TNF levels (EC50=4.5 µM) in mice, making it useful for autoimmune and infl... | |||
T74453 | JPS014 | ||
JPS014, a benzamide-based Von Hippel-Lindau (VHL) E3-ligase proteolysis targeting chimera (PROTAC), effectively degrades class I histone deacetylase (HDAC), exhibiting potency as an HDAC1/2 degrader. This correlation is ... | |||
T77937 | JPS014 TFA | HDAC | |
JPS014 TFA, a benzamide-based Von Hippel-Lindau (VHL) E3-ligase proteolysis targeting chimera (PROTAC), effectively degrades class I histone deacetylase (HDAC), particularly HDAC1/2. This activity is associated with a hi... | |||
T74455 | JPS035 | ||
JPS035, a benzamide-based Von Hippel-Lindau (VHL) E3-ligase proteolysis targeting chimera (PROTAC), effectively degrades class I histone deacetylase (HDAC), specifically HDAC1/2. Its potent activity is associated with an... | |||
T69955 | JPI-547 HCl | ||
JPI 547, also known as NOV 1402, is an oral inhibitor of PARP 1/2 and Tankyrase 1/2. JPI-547 demonstrated anti-tumor activity in BRCA-deficient xenograft models as a single-agent and in combination with chemotherapy and ... | |||
T78593 | JP104 | FAAH | |
JP104 is an aryl carbamate that irreversibly inhibits fatty acid amide hydrolase (FAAH) with a pIC50 value of approximately 8 [1]. | |||
T27693 | JPC-211 | JPC 211,PNU-99194A free base | |
JPC-211 is an agonist of dopamine-receptor. |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-00732 | Cathepsin C Protein, Human, Recombinant (His) | Human | HEK293 |
Cathepsins are proteases found in many types of cells conserved in all animals, which have a vital role in mammalian cellular turnover such as bone resorption. The lysosomal cysteine protease Cathepsin C (CTSC), also kno... | |||
TMPH-00065 | MRJP1 Protein, Apis mellifera, Recombinant (GST) | Apis mellifera | E. coli |
Induces the differentiation of honeybee larvae into queens through an Egfr-mediated signaling pathway. Promotes body size increase by activating p70 S6 kinase, stimulates ovary development by augmenting the titer of vite... | |||
TMPH-00064 | MRJP1 Protein, Apis mellifera, Recombinant (His) | Apis mellifera | Yeast |
Induces the differentiation of honeybee larvae into queens through an Egfr-mediated signaling pathway. Promotes body size increase by activating p70 S6 kinase, stimulates ovary development by augmenting the titer of vite... | |||
TMPY-04061 | HIV-2 (subtype CRF01_AB, strain 07JP_NMC716_clone_01) gp36 Protein (His & MBP) | HIV | E. coli |
HIV-2 (subtype CRF01_AB, strain 07JP_NMC716_clone_01) gp36 Protein (His & MBP) is expressed in E. coli with His and MBP tag. The predicted molecular weight is 58.8 kDa. Accession number: L8B302 |
Cat No. | Product Name | ||
---|---|---|---|
L1010 | FDA-Approved & Pharmacopeia Drug Library | 3157 compounds | |
3157 compounds from marketed drugs for high throughput screening (HTS) and high content screening (HCS); |